APRE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.80%

Insider Buying (Last 12 Months): $175,215.70

Insider Selling (Last 12 Months): $29,595.96

Aprea Therapeutics Insider Trading History Chart

Aprea Therapeutics Share Price & Price History

^$1.70

▼ -0.1 (-5.56%)

As of 04/4/2025 04:54 PM ET

Days: 30 | 90 | 365

Aprea Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/3/2025	Oren Gilad	CEO	Buy	5,500	$1.84	$10,120.00	345,620
10/23/2024	Oren Gilad	CEO	Buy	500	$3.92	$1,960.00	333,395
10/18/2024	Marc Duey	Director	Sell	6,462	$4.58	$29,595.96	233,651
10/16/2024	Marc Duey	Director	Buy	30,000	$4.39	$131,700.00	240,113
10/14/2024	Marc Duey	Director	Buy	190	$2.58	$490.20	210,113
10/14/2024	Oren Gilad	CEO	Buy	1,000	$2.59	$2,590.00	332,645
10/11/2024	Bernd R Seizinger	Director	Buy	10,000	$2.68	$26,800.00	44,730
10/10/2024	John P Hamill	CFO	Buy	450	$2.61	$1,174.50	19,318
10/10/2024	Oren Gilad	CEO	Buy	150	$2.54	$381.00	331,645
3/13/2024	Bernd R Seizinger	Director	Buy	6,860	$7.29	$50,009.40	33,685
3/13/2024	John P Hamill	CFO	Buy	1,010	$7.29	$7,362.90	15,503
3/13/2024	Oren Gilad	CEO	Buy	2,000	$7.29	$14,580.00	324,770
6/6/2023	Bernd R Seizinger	Director	Buy	4,068	$3.63	$14,766.84	20,296

See Full Table

SEC Filings (Institutional Ownership Changes) for Aprea Therapeutics (NASDAQ:APRE)

34.19% of Aprea Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aprea Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Stonepine Capital Management LLC	149,221	$0.49M	0.4%	+8.8%	2.748%
2/17/2025	BNP Paribas Financial Markets	13,011	$43K	0.0%	N/A	0.240%
2/12/2025	Landscape Capital Management L.L.C.	35,328	$0.12M	0.0%	N/A	0.651%
2/11/2025	LPL Financial LLC	16,052	$53K	0.0%	N/A	0.296%
8/21/2024	Stonepine Capital Management LLC	137,174	$0.56M	0.5%	N/A	2.526%
8/9/2024	Dimensional Fund Advisors LP	11,071	$45K	0.0%	N/A	0.204%
5/15/2023	AIGH Capital Management LLC	345,000	$1.53M	0.6%	N/A	9.244%
5/15/2023	Sio Capital Management LLC	280,000	$1.24M	0.6%	N/A	7.503%
5/12/2022	Gyon Technologies Capital Management LP	20,570	$38K	0.0%	N/A	0.094%
5/12/2022	Magnus Financial Group LLC	14,856	$28K	0.0%	-56.3%	0.068%
2/15/2022	Kennedy Capital Management Inc.	336,730	$0.97M	0.0%	-1.7%	1.569%
2/14/2022	PDT Partners LLC	142,600	$0.41M	0.0%	+62.5%	0.664%
2/10/2022	Magnus Financial Group LLC	33,981	$98K	0.0%	N/A	0.158%
11/16/2021	Verition Fund Management LLC	20,101	$0.10M	0.0%	N/A	0.094%
11/12/2021	Geode Capital Management LLC	198,339	$1.01M	0.0%	+89.9%	0.936%
11/10/2021	Goldman Sachs Group Inc.	144,758	$0.74M	0.0%	+131.4%	0.683%
11/9/2021	BlackRock Inc.	354,275	$1.81M	0.0%	-0.9%	1.672%
9/17/2021	Virtu Financial LLC	41,142	$0.20M	0.0%	+292.9%	0.194%
8/17/2021	Walleye Capital LLC	98,931	$0.48M	0.0%	-16.5%	0.467%
8/17/2021	Walleye Trading LLC	27,455	$0.13M	0.0%	-33.4%	0.130%
8/16/2021	PDT Partners LLC	124,234	$0.61M	0.0%	N/A	0.586%
8/16/2021	Morgan Stanley	1,019,776	$4.98M	0.0%	+2.2%	4.813%
8/16/2021	Kennedy Capital Management Inc.	353,926	$1.73M	0.0%	+575.2%	1.670%
8/16/2021	Charles Schwab Investment Management Inc.	50,366	$0.25M	0.0%	-26.5%	0.238%
8/16/2021	State Street Corp	40,832	$0.20M	0.0%	-67.2%	0.193%
8/16/2021	Goldman Sachs Group Inc.	62,546	$0.31M	0.0%	-14.4%	0.295%
8/13/2021	Northern Trust Corp	32,530	$0.16M	0.0%	-69.2%	0.154%
8/13/2021	Geode Capital Management LLC	104,447	$0.51M	0.0%	-35.2%	0.493%
8/13/2021	Vanguard Group Inc.	707,422	$3.45M	0.0%	-6.0%	3.339%
8/12/2021	SG Americas Securities LLC	598,395	$2.92M	0.0%	-8.8%	2.824%
8/12/2021	JPMorgan Chase & Co.	60,315	$0.29M	0.0%	+264.4%	0.285%
8/12/2021	Ergoteles LLC	18,570	$91K	0.0%	N/A	0.088%
8/11/2021	Great Lakes Advisors LLC	17,895	$87K	0.0%	N/A	0.084%
8/11/2021	Bank of New York Mellon Corp	16,843	$83K	0.0%	-64.8%	0.079%
5/19/2021	Virtu Financial LLC	10,471	$53K	0.0%	-56.4%	0.049%
5/18/2021	Voloridge Investment Management LLC	304,198	$1.55M	0.0%	N/A	1.436%
5/18/2021	Morgan Stanley	998,127	$5.09M	0.0%	+111.0%	4.711%
5/18/2021	Redmile Group LLC	694,918	$3.54M	0.0%	-45.2%	3.280%
5/17/2021	Royal Bank of Canada	15,173	$76K	0.0%	+76.5%	0.072%
5/17/2021	Walleye Trading LLC	41,254	$0.21M	0.0%	+7.4%	0.195%
5/17/2021	Walleye Capital LLC	118,476	$0.60M	0.0%	+17.5%	0.559%
5/17/2021	HRT Financial LP	73,587	$0.38M	0.0%	N/A	0.347%
5/17/2021	Nuveen Asset Management LLC	17,565	$90K	0.0%	-48.7%	0.083%
5/17/2021	5AM Venture Management LLC	619,157	$3.16M	0.6%	-55.1%	2.922%
5/17/2021	Goldman Sachs Group Inc.	73,107	$0.37M	0.0%	N/A	0.345%
5/14/2021	Kennedy Capital Management Inc.	52,415	$0.27M	0.0%	N/A	0.247%
5/14/2021	FIL Ltd	83,191	$0.42M	0.0%	+17,267.6%	0.393%
5/14/2021	UBS Asset Management Americas Inc.	22,700	$0.12M	0.0%	N/A	0.107%
5/13/2021	Trexquant Investment LP	25,361	$0.13M	0.0%	N/A	0.120%
5/13/2021	SG Americas Securities LLC	655,888	$3.35M	0.0%	+2,725.9%	3.096%
5/13/2021	Bank of New York Mellon Corp	47,783	$0.24M	0.0%	+57.5%	0.226%
5/12/2021	Northern Trust Corp	105,719	$0.54M	0.0%	-6.8%	0.499%
5/12/2021	Geode Capital Management LLC	161,147	$0.82M	0.0%	+9.1%	0.761%
5/12/2021	JPMorgan Chase & Co.	16,550	$85K	0.0%	+380.3%	0.078%
5/7/2021	BlackRock Inc.	810,852	$4.14M	0.0%	-2.1%	3.827%
5/7/2021	Versant Venture Management LLC	1,259,662	$6.42M	1.3%	-11.7%	5.945%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	8,254	$42K	0.0%	N/A	0.039%
4/16/2021	NEXT Financial Group Inc	11,765	$60K	0.0%	N/A	0.056%
3/12/2021	DekaBank Deutsche Girozentrale	7,000	$35K	0.0%	N/A	0.033%
2/24/2021	Virtu Financial LLC	24,029	$0.12M	0.0%	N/A	0.113%
2/17/2021	Jane Street Group LLC	11,856	$58K	0.0%	N/A	0.056%
2/16/2021	Squarepoint Ops LLC	26,182	$0.13M	0.0%	+179.4%	0.124%
2/16/2021	Nuveen Asset Management LLC	34,257	$0.17M	0.0%	+20.5%	0.162%
2/16/2021	Price T Rowe Associates Inc. MD	29,874	$0.15M	0.0%	-90.2%	0.141%
2/12/2021	Credit Suisse AG	33,976	$0.17M	0.0%	+201.3%	0.160%
2/11/2021	Northern Trust Corp	113,424	$0.56M	0.0%	-3.9%	0.535%
2/9/2021	Wells Fargo & Company MN	5,523	$27K	0.0%	-55.4%	0.026%
2/9/2021	Bank of New York Mellon Corp	30,336	$0.15M	0.0%	+6.4%	0.143%

Data available starting January 2016

See Full Table

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Today's Range

Now: $1.70

$1.67

$1.85

50 Day Range

MA: $2.81

$1.70

$4.06

52 Week Range

Now: $1.70

$1.67

$6.40

Volume

89,919 shs

Average Volume

19,711 shs

Market Capitalization

$9.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Aprea Therapeutics?: Aprea Therapeutics' top insider shareholders include:
Oren Gilad (CEO)
Marc Duey (Director)
Bernd R Seizinger (Director)
John P Hamill (CFO)
Learn More about top insider investors at Aprea Therapeutics.